Key result
Rare genetic variants in ANKRD26 were significantly associated with ADP-induced platelet aggregation (P = 7.13 × 10–7), with aggregation increases of 20–50% observed in heterozygotes.
Why the study?
Are low frequency or rare genetic variants associated with altered platelet aggregation?
Meta-Analysis (n=4,000)
Yes
Are low frequency or rare genetic variants associated with altered platelet aggregation?
Rare genetic variants in ANKRD26 and HCP5 are significantly associated with increased ADP-induced platelet aggregation, highlighting novel genetic determinants of platelet function.
Answers are grounded in this paper and cite their sources.
May inform antiplatelet response variability in carriers; extends the genetic architecture of platelet reactivity.
Previous genome-wide association studies (GWAS) have identified several variants associated with platelet function phenotypes; however, the proportion of variance explained by the identified variants is mostly small. Rare coding variants, particularly those with high potential for impact on protein structure/function, may have substantial impact on phenotype but are difficult to detect by GWAS. The main purpose of this study was to identify low frequency or rare variants associated with platelet function using genotype data from the Illumina HumanExome Bead Chip. Three family-based cohorts of European ancestry, including ~4,000 total subjects, comprised the discovery cohort and two independent cohorts, one of European and one of African American ancestry, were used for replication. Optical aggregometry in platelet-rich plasma was performed in all the discovery cohorts in response to adenosine diphosphate (ADP), epinephrine, and collagen. Meta-analyses were performed using both gene-based and single nucleotide variant association methods. The gene-based meta-analysis identified a significant association (P = 7.13 × 10–7) between rare genetic variants in ANKRD26 and ADP-induced platelet aggregation. One of the ANKRD26 SNVs - rs191015656, encoding a threonine to isoleucine substitution predicted to alter protein structure/function, was replicated in Europeans. Aggregation increases of ~20–50% were observed in heterozygotes in all cohorts. Novel genetic signals in ABCG1 and HCP5 were also associated with platelet aggregation to ADP in meta-analyses, although only results for HCP5 could be replicated. The SNV in HCP5 intersects epigenetic signatures in CD41+ megakaryocytes suggesting a new functional role in platelet biology for HCP5. This is the first study to use gene-based association methods from SNV array genotypes to identify rare variants related to platelet function. The molecular mechanisms and pathophysiological relevance for the identified genetic associations requires further study.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2017) conducted a meta-analysis in Platelet aggregation (n=4,000). Rare genetic variants in ANKRD26 vs. Non-carriers was evaluated on ADP-induced platelet aggregation (p=7.13 × 10–7). Rare genetic variants in ANKRD26 were significantly associated with ADP-induced platelet aggregation (P = 7.13 × 10–7), with aggregation increases of 20–50% observed in heterozygotes.
Synapse has enriched 10 related papers. Consider them for comparative context: